Accenture Life Sciences Blog
Pharmaceutical and medical technology companies face both complexity and opportunity when navigating the current healthcare landscape. Accenture experts will share their insights and opinions on how pharmaceutical and medical technology companies can rethink, reshape and restructure for better patient outcomes during complex times.
 
 
In the last decade, scientific advances in the medical environment have allowed us to identify the underlying causes of major diseases with increased understanding—leading the way towards personalized medicine. In this new era, each patient requir...
 
 
 
 
Patient health monitoring via wearable devices is set to revolutionize the life sciences industry over the next few years. According to the Institute for Health Studies, Wearable Technology - Market Assessment, roughly 50 million wearable units w...
 
 
 
 
The recent webinar co-hosted by Salesforce.com and Accenture on how social, mobile and cloud are transforming health and pharma was attended by over 200 executives. With healthcare costs and product innovation at a crossroads, the subject of how d...
 
 
 
 
As mergers and acquisitions (M&A) in the life sciences industry continue to dominate the headlines, what is keeping life sciences executives awake at night? Where are they placing their bets to achieve growth and/or operational improvement? An...
 
 
 
 
A major factor identified in our recently published research note, The Changing Future of Consumer Healthcare, is the evolution taking place for consumers who are increasingly taking charge of their own health and wellness. In addition to the incr...
 
 
 
 
Sander van ‘t Noordende our Products Group Chief Executive recently posted an insightful piece on his LinkedIn page that highlights the incredible power of combining Electronic Medical Records (EMR) with other data sources to change how we treat pat...
 
 
 
 
What makes digitally enabled life sciences companies different? These companies challenge the traditional product-focused business models, disrupt the traditional view of their role in healthcare and look at digital in a holistic way. They use dig...
 
 
 
 
Earlier this year, Accenture Technology Labs released the Technology Vision for 2014, our annual view of emerging tech trends that impact our clients. The report outlined how every business is still a digital business, but explored a recent trend ...
 
 
 
 
“Mum’s Not Molecules” - Reckitt Benckiser CEO Rakesh Kapoor positions the future of consumer healthcare in listening to what improves the lives of consumers. In a conference interview on June 14, Reckitt Benckiser’s (RB) CEO outlined a bold visio...
 
 
 
 
Accenture recently published our High Performing Business (HPB) research note, The Changing Future of Consumer Healthcare, which highlighted the significant changes expected in the consumer health marketplace over the next five years. While we exp...
 
 
 Next >>
About the Authors
Anne O'Riordan
Anne O'Riordan is Senior Managing Director responsible for Accenture's Global Life Sciences Practice. Worked throughout Europe, the ...
 

Photo of Jeffrey Russell

Jeffrey Russell is managing director of Accenture Life Sciences in North America.

Russell has more than 20 years of exper...
 
Doug Mowen
Doug Mowen is the managing director for Accenture’s Medical Technology Practice. With 25 years of experience and 15 years serving th...
 
Jeff Elton
Jeff Elton, managing director of Accenture Life Sciences, has broad responsibilities for the strategy and partnerships for ne...
 
Shawn Roman
Shawn Roman is a managing director in Accenture Life Sciences and leads the North America Commercial Services practice. Mr. Roman h...
 
 

 

By using this site you agree that we can place cookies on your device. See our privacy statement for details.